ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COVID-19 Neutralizing Antibody Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-19C12902
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global COVID 19 Neutralizing Antibody Drugs Market Research Report 2022
BUY CHAPTERS

Global COVID-19 Neutralizing Antibody Drugs Market Research Report 2025

Code: QYRE-Auto-19C12902
Report
February 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Tychan
Astrazeneca plc
Abpro
Shanghai Junshi Biosciences
Sinocelltech Ltd
BeiGene Ltd
Molecular Partners AG/诺华
Brii Biosciences
Mabwell Bioscience
Regeneron Pharmaceuticals
Eli Lilly

COVID-19 Neutralizing Antibody Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Neutralizing Antibody Drugs Market

COVID-19 Neutralizing Antibody Drugs Market

The global market for COVID-19 Neutralizing Antibody Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The main mechanism of action of the COVID-19 neutralizing antibody drugs is to neutralize the new coronavirus and prevent the virus from being adsorbed on susceptible cells, thereby blocking the virus or its genetic material from entering the intracellular proliferation.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COVID-19 Neutralizing Antibody Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Neutralizing Antibody Drugs.
The COVID-19 Neutralizing Antibody Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COVID-19 Neutralizing Antibody Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Neutralizing Antibody Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of COVID-19 Neutralizing Antibody Drugs Market Report

Report Metric Details
Report Name COVID-19 Neutralizing Antibody Drugs Market
CAGR 5%
Segment by Type
  • ACE2 Fusion Protein
  • Neutralizing Antibody
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Tychan, AstraZeneca, Molecular Partners AG/诺华, Eli Lilly, Regeneron Pharmaceuticals, Abpro, Shanghai Junshi Biosciences, Brii Biosciences, Mabwell Bioscience, Sinocelltech, BeiGene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of COVID-19 Neutralizing Antibody Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of COVID-19 Neutralizing Antibody Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the COVID-19 Neutralizing Antibody Drugs Market report?

Ans: The main players in the COVID-19 Neutralizing Antibody Drugs Market are Tychan, AstraZeneca, Molecular Partners AG/诺华, Eli Lilly, Regeneron Pharmaceuticals, Abpro, Shanghai Junshi Biosciences, Brii Biosciences, Mabwell Bioscience, Sinocelltech, BeiGene

What are the Application segmentation covered in the COVID-19 Neutralizing Antibody Drugs Market report?

Ans: The Applications covered in the COVID-19 Neutralizing Antibody Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the COVID-19 Neutralizing Antibody Drugs Market report?

Ans: The Types covered in the COVID-19 Neutralizing Antibody Drugs Market report are ACE2 Fusion Protein, Neutralizing Antibody

Recommended Reports

COVID-19 Drugs

Antibody Drugs

Infectious Disease

1 COVID-19 Neutralizing Antibody Drugs Market Overview
1.1 Product Definition
1.2 COVID-19 Neutralizing Antibody Drugs by Type
1.2.1 Global COVID-19 Neutralizing Antibody Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 ACE2 Fusion Protein
1.2.3 Neutralizing Antibody
1.3 COVID-19 Neutralizing Antibody Drugs by Application
1.3.1 Global COVID-19 Neutralizing Antibody Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global COVID-19 Neutralizing Antibody Drugs Market Size Estimates and Forecasts
1.4.1 Global COVID-19 Neutralizing Antibody Drugs Revenue 2020-2031
1.4.2 Global COVID-19 Neutralizing Antibody Drugs Sales 2020-2031
1.4.3 Global COVID-19 Neutralizing Antibody Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 COVID-19 Neutralizing Antibody Drugs Market Competition by Manufacturers
2.1 Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global COVID-19 Neutralizing Antibody Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of COVID-19 Neutralizing Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Product Type & Application
2.7 Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Date of Enter into This Industry
2.8 Global COVID-19 Neutralizing Antibody Drugs Market Competitive Situation and Trends
2.8.1 Global COVID-19 Neutralizing Antibody Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest COVID-19 Neutralizing Antibody Drugs Players Market Share by Revenue
2.8.3 Global COVID-19 Neutralizing Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COVID-19 Neutralizing Antibody Drugs Market Scenario by Region
3.1 Global COVID-19 Neutralizing Antibody Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global COVID-19 Neutralizing Antibody Drugs Sales by Region: 2020-2031
3.2.1 Global COVID-19 Neutralizing Antibody Drugs Sales by Region: 2020-2025
3.2.2 Global COVID-19 Neutralizing Antibody Drugs Sales by Region: 2026-2031
3.3 Global COVID-19 Neutralizing Antibody Drugs Revenue by Region: 2020-2031
3.3.1 Global COVID-19 Neutralizing Antibody Drugs Revenue by Region: 2020-2025
3.3.2 Global COVID-19 Neutralizing Antibody Drugs Revenue by Region: 2026-2031
3.4 North America COVID-19 Neutralizing Antibody Drugs Market Facts & Figures by Country
3.4.1 North America COVID-19 Neutralizing Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2031)
3.4.3 North America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe COVID-19 Neutralizing Antibody Drugs Market Facts & Figures by Country
3.5.1 Europe COVID-19 Neutralizing Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2031)
3.5.3 Europe COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COVID-19 Neutralizing Antibody Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific COVID-19 Neutralizing Antibody Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific COVID-19 Neutralizing Antibody Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific COVID-19 Neutralizing Antibody Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America COVID-19 Neutralizing Antibody Drugs Market Facts & Figures by Country
3.7.1 Latin America COVID-19 Neutralizing Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2031)
3.7.3 Latin America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COVID-19 Neutralizing Antibody Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa COVID-19 Neutralizing Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COVID-19 Neutralizing Antibody Drugs Sales by Type (2020-2031)
4.1.1 Global COVID-19 Neutralizing Antibody Drugs Sales by Type (2020-2025)
4.1.2 Global COVID-19 Neutralizing Antibody Drugs Sales by Type (2026-2031)
4.1.3 Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Type (2020-2031)
4.2 Global COVID-19 Neutralizing Antibody Drugs Revenue by Type (2020-2031)
4.2.1 Global COVID-19 Neutralizing Antibody Drugs Revenue by Type (2020-2025)
4.2.2 Global COVID-19 Neutralizing Antibody Drugs Revenue by Type (2026-2031)
4.2.3 Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Type (2020-2031)
4.3 Global COVID-19 Neutralizing Antibody Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global COVID-19 Neutralizing Antibody Drugs Sales by Application (2020-2031)
5.1.1 Global COVID-19 Neutralizing Antibody Drugs Sales by Application (2020-2025)
5.1.2 Global COVID-19 Neutralizing Antibody Drugs Sales by Application (2026-2031)
5.1.3 Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Application (2020-2031)
5.2 Global COVID-19 Neutralizing Antibody Drugs Revenue by Application (2020-2031)
5.2.1 Global COVID-19 Neutralizing Antibody Drugs Revenue by Application (2020-2025)
5.2.2 Global COVID-19 Neutralizing Antibody Drugs Revenue by Application (2026-2031)
5.2.3 Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Application (2020-2031)
5.3 Global COVID-19 Neutralizing Antibody Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Tychan
6.1.1 Tychan Company Information
6.1.2 Tychan Description and Business Overview
6.1.3 Tychan COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Tychan COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.1.5 Tychan Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Molecular Partners AG/诺华
6.3.1 Molecular Partners AG/诺华 Company Information
6.3.2 Molecular Partners AG/诺华 Description and Business Overview
6.3.3 Molecular Partners AG/诺华 COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Molecular Partners AG/诺华 COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.3.5 Molecular Partners AG/诺华 Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Regeneron Pharmaceuticals
6.5.1 Regeneron Pharmaceuticals Company Information
6.5.2 Regeneron Pharmaceuticals Description and Business Overview
6.5.3 Regeneron Pharmaceuticals COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Regeneron Pharmaceuticals COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.5.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.6 Abpro
6.6.1 Abpro Company Information
6.6.2 Abpro Description and Business Overview
6.6.3 Abpro COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abpro COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.6.5 Abpro Recent Developments/Updates
6.7 Shanghai Junshi Biosciences
6.7.1 Shanghai Junshi Biosciences Company Information
6.7.2 Shanghai Junshi Biosciences Description and Business Overview
6.7.3 Shanghai Junshi Biosciences COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Junshi Biosciences COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.7.5 Shanghai Junshi Biosciences Recent Developments/Updates
6.8 Brii Biosciences
6.8.1 Brii Biosciences Company Information
6.8.2 Brii Biosciences Description and Business Overview
6.8.3 Brii Biosciences COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Brii Biosciences COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.8.5 Brii Biosciences Recent Developments/Updates
6.9 Mabwell Bioscience
6.9.1 Mabwell Bioscience Company Information
6.9.2 Mabwell Bioscience Description and Business Overview
6.9.3 Mabwell Bioscience COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mabwell Bioscience COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.9.5 Mabwell Bioscience Recent Developments/Updates
6.10 Sinocelltech
6.10.1 Sinocelltech Company Information
6.10.2 Sinocelltech Description and Business Overview
6.10.3 Sinocelltech COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sinocelltech COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.10.5 Sinocelltech Recent Developments/Updates
6.11 BeiGene
6.11.1 BeiGene Company Information
6.11.2 BeiGene Description and Business Overview
6.11.3 BeiGene COVID-19 Neutralizing Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BeiGene COVID-19 Neutralizing Antibody Drugs Product Portfolio
6.11.5 BeiGene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COVID-19 Neutralizing Antibody Drugs Industry Chain Analysis
7.2 COVID-19 Neutralizing Antibody Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COVID-19 Neutralizing Antibody Drugs Production Mode & Process Analysis
7.4 COVID-19 Neutralizing Antibody Drugs Sales and Marketing
7.4.1 COVID-19 Neutralizing Antibody Drugs Sales Channels
7.4.2 COVID-19 Neutralizing Antibody Drugs Distributors
7.5 COVID-19 Neutralizing Antibody Drugs Customer Analysis
8 COVID-19 Neutralizing Antibody Drugs Market Dynamics
8.1 COVID-19 Neutralizing Antibody Drugs Industry Trends
8.2 COVID-19 Neutralizing Antibody Drugs Market Drivers
8.3 COVID-19 Neutralizing Antibody Drugs Market Challenges
8.4 COVID-19 Neutralizing Antibody Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Tychan
Astrazeneca plc
Abpro
Shanghai Junshi Biosciences
Sinocelltech Ltd
BeiGene Ltd
Molecular Partners AG/诺华
Brii Biosciences
Mabwell Bioscience
Regeneron Pharmaceuticals
Eli Lilly
List of Tables
 Table 1. Global COVID-19 Neutralizing Antibody Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global COVID-19 Neutralizing Antibody Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global COVID-19 Neutralizing Antibody Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global COVID-19 Neutralizing Antibody Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global COVID-19 Neutralizing Antibody Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global COVID-19 Neutralizing Antibody Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market COVID-19 Neutralizing Antibody Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of COVID-19 Neutralizing Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of COVID-19 Neutralizing Antibody Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global COVID-19 Neutralizing Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Neutralizing Antibody Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global COVID-19 Neutralizing Antibody Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global COVID-19 Neutralizing Antibody Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global COVID-19 Neutralizing Antibody Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global COVID-19 Neutralizing Antibody Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global COVID-19 Neutralizing Antibody Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America COVID-19 Neutralizing Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America COVID-19 Neutralizing Antibody Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe COVID-19 Neutralizing Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe COVID-19 Neutralizing Antibody Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe COVID-19 Neutralizing Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific COVID-19 Neutralizing Antibody Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific COVID-19 Neutralizing Antibody Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific COVID-19 Neutralizing Antibody Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific COVID-19 Neutralizing Antibody Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific COVID-19 Neutralizing Antibody Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America COVID-19 Neutralizing Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America COVID-19 Neutralizing Antibody Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America COVID-19 Neutralizing Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global COVID-19 Neutralizing Antibody Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global COVID-19 Neutralizing Antibody Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global COVID-19 Neutralizing Antibody Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global COVID-19 Neutralizing Antibody Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global COVID-19 Neutralizing Antibody Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global COVID-19 Neutralizing Antibody Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global COVID-19 Neutralizing Antibody Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global COVID-19 Neutralizing Antibody Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global COVID-19 Neutralizing Antibody Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Tychan Company Information
 Table 71. Tychan Description and Business Overview
 Table 72. Tychan COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Tychan COVID-19 Neutralizing Antibody Drugs Product
 Table 74. Tychan Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca COVID-19 Neutralizing Antibody Drugs Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Molecular Partners AG/诺华 Company Information
 Table 81. Molecular Partners AG/诺华 Description and Business Overview
 Table 82. Molecular Partners AG/诺华 COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Molecular Partners AG/诺华 COVID-19 Neutralizing Antibody Drugs Product
 Table 84. Molecular Partners AG/诺华 Recent Developments/Updates
 Table 85. Eli Lilly Company Information
 Table 86. Eli Lilly Description and Business Overview
 Table 87. Eli Lilly COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly COVID-19 Neutralizing Antibody Drugs Product
 Table 89. Eli Lilly Recent Developments/Updates
 Table 90. Regeneron Pharmaceuticals Company Information
 Table 91. Regeneron Pharmaceuticals Description and Business Overview
 Table 92. Regeneron Pharmaceuticals COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Regeneron Pharmaceuticals COVID-19 Neutralizing Antibody Drugs Product
 Table 94. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 95. Abpro Company Information
 Table 96. Abpro Description and Business Overview
 Table 97. Abpro COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Abpro COVID-19 Neutralizing Antibody Drugs Product
 Table 99. Abpro Recent Developments/Updates
 Table 100. Shanghai Junshi Biosciences Company Information
 Table 101. Shanghai Junshi Biosciences Description and Business Overview
 Table 102. Shanghai Junshi Biosciences COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai Junshi Biosciences COVID-19 Neutralizing Antibody Drugs Product
 Table 104. Shanghai Junshi Biosciences Recent Developments/Updates
 Table 105. Brii Biosciences Company Information
 Table 106. Brii Biosciences Description and Business Overview
 Table 107. Brii Biosciences COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Brii Biosciences COVID-19 Neutralizing Antibody Drugs Product
 Table 109. Brii Biosciences Recent Developments/Updates
 Table 110. Mabwell Bioscience Company Information
 Table 111. Mabwell Bioscience Description and Business Overview
 Table 112. Mabwell Bioscience COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mabwell Bioscience COVID-19 Neutralizing Antibody Drugs Product
 Table 114. Mabwell Bioscience Recent Developments/Updates
 Table 115. Sinocelltech Company Information
 Table 116. Sinocelltech Description and Business Overview
 Table 117. Sinocelltech COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sinocelltech COVID-19 Neutralizing Antibody Drugs Product
 Table 119. Sinocelltech Recent Developments/Updates
 Table 120. BeiGene Company Information
 Table 121. BeiGene Description and Business Overview
 Table 122. BeiGene COVID-19 Neutralizing Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BeiGene COVID-19 Neutralizing Antibody Drugs Product
 Table 124. BeiGene Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. COVID-19 Neutralizing Antibody Drugs Distributors List
 Table 128. COVID-19 Neutralizing Antibody Drugs Customers List
 Table 129. COVID-19 Neutralizing Antibody Drugs Market Trends
 Table 130. COVID-19 Neutralizing Antibody Drugs Market Drivers
 Table 131. COVID-19 Neutralizing Antibody Drugs Market Challenges
 Table 132. COVID-19 Neutralizing Antibody Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of COVID-19 Neutralizing Antibody Drugs
 Figure 2. Global COVID-19 Neutralizing Antibody Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global COVID-19 Neutralizing Antibody Drugs Market Share by Type: 2024 & 2031
 Figure 4. ACE2 Fusion Protein Product Picture
 Figure 5. Neutralizing Antibody Product Picture
 Figure 6. Global COVID-19 Neutralizing Antibody Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global COVID-19 Neutralizing Antibody Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global COVID-19 Neutralizing Antibody Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global COVID-19 Neutralizing Antibody Drugs Market Size (2020-2031) & (US$ Million)
 Figure 12. Global COVID-19 Neutralizing Antibody Drugs Sales (2020-2031) & (K Units)
 Figure 13. Global COVID-19 Neutralizing Antibody Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 14. COVID-19 Neutralizing Antibody Drugs Report Years Considered
 Figure 15. COVID-19 Neutralizing Antibody Drugs Sales Share by Manufacturers in 2024
 Figure 16. Global COVID-19 Neutralizing Antibody Drugs Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest COVID-19 Neutralizing Antibody Drugs Players: Market Share by Revenue in COVID-19 Neutralizing Antibody Drugs in 2024
 Figure 18. COVID-19 Neutralizing Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global COVID-19 Neutralizing Antibody Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America COVID-19 Neutralizing Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 21. North America COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 22. United States COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe COVID-19 Neutralizing Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 25. Europe COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. Germany COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific COVID-19 Neutralizing Antibody Drugs Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Region (2020-2031)
 Figure 33. China COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America COVID-19 Neutralizing Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 41. Latin America COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa COVID-19 Neutralizing Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE COVID-19 Neutralizing Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of COVID-19 Neutralizing Antibody Drugs by Type (2020-2031)
 Figure 51. Global Revenue Market Share of COVID-19 Neutralizing Antibody Drugs by Type (2020-2031)
 Figure 52. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of COVID-19 Neutralizing Antibody Drugs by Application (2020-2031)
 Figure 54. Global Revenue Market Share of COVID-19 Neutralizing Antibody Drugs by Application (2020-2031)
 Figure 55. Global COVID-19 Neutralizing Antibody Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 56. COVID-19 Neutralizing Antibody Drugs Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Covid 19 Antibody Test Market Research Report 2024
Global COVID 19 Medicine Market Research Report 2024
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specific Antiviral Drugs for COVID 19 Market
Global Oral COVID 19 Drug Market Research Report 2025
Global COVID 19 Antigen Detection Reagent Market Research Report 2025
Coronavirus Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Approved COVID 19 Vaccines Market Research Report 2025
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Antigen Testing Devices Market Research Report 2025
Coronavirus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Antibody Rapid Test Kits Market Research Report 2025
Biologic Medication in COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti COVID 19 Compound Library Market Research Report 2025
Global COVID 19 Antigen Detection Kit Market Research Report 2025
Global COVID 19 Detection Reagent Market Research Report 2024
COVID 19 Vaccines Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Treatment Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions